Mission Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $886K | Buy |
11,330
+7,087
| +167% | +$572K | 0.01% | 512 |
|
|
2026
Q1 | $368K | Sell |
4,243
-275
| -6% | -$26.3K | 0.01% | 566 |
|
|
2025
Q4 | $434K | Buy |
4,518
+74
| +2% | +$7.19K | 0.01% | 520 |
|
|
2025
Q3 | $423K | Buy |
4,444
+84
| +2% | +$7.72K | 0.01% | 524 |
|
|
2025
Q2 | $380K | Sell |
4,360
-598
| -12% | -$50.7K | 0.01% | 539 |
|
|
2025
Q1 | $446K | Sell |
4,958
-493
| -9% | -$44.1K | 0.01% | 487 |
|
|
2024
Q4 | $435K | Sell |
5,451
-19
| -0.3% | -$1.65K | 0.01% | 452 |
|
|
2024
Q3 | $492K | Sell |
5,470
-200
| -4% | -$16.8K | 0.01% | 434 |
|
|
2024
Q2 | $446K | Sell |
5,670
-581
| -9% | -$47.6K | 0.01% | 437 |
|
|
2024
Q1 | $545K | Buy |
6,251
+718
| +13% | +$61.3K | 0.01% | 413 |
|
|
2023
Q4 | $456K | Sell |
5,533
-593
| -10% | -$45.2K | 0.01% | 389 |
|
|
2023
Q3 | $480K | Buy |
6,126
+74
| +1% | +$6.2K | 0.02% | 346 |
|
|
2023
Q2 | $533K | Sell |
6,052
-289
| -5% | -$24.9K | 0.02% | 333 |
|
|
2023
Q1 | $511K | Buy |
6,341
+40
| +0.6% | +$3.26K | 0.02% | 329 |
|
|
2022
Q4 | $490K | Sell |
6,301
-352
| -5% | -$28.5K | 0.02% | 321 |
|
|
2022
Q3 | $537K | Sell |
6,653
-73
| -1% | -$6.56K | 0.03% | 286 |
|
|
2022
Q2 | $604K | Sell |
6,726
-634
| -9% | -$64.2K | 0.03% | 273 |
|
|
2022
Q1 | $816K | Sell |
7,360
-361
| -5% | -$38.1K | 0.04% | 231 |
|
|
2021
Q4 | $799K | Buy |
7,721
+1,017
| +15% | +$118K | 0.04% | 224 |
|
|
2021
Q3 | $840K | Buy |
6,704
+353
| +6% | +$45.7K | 0.04% | 205 |
|
|
2021
Q2 | $788K | Sell |
6,351
-292
| -4% | -$36.7K | 0.04% | 200 |
|
|
2021
Q1 | $785K | Buy |
6,643
+322
| +5% | +$37.7K | 0.05% | 175 |
|
|
2020
Q4 | $740K | Buy |
6,321
+203
| +3% | +$22.3K | 0.05% | 171 |
|
|
2020
Q3 | $636K | Buy |
6,118
+1,792
| +41% | +$180K | 0.05% | 168 |
|
|
2020
Q2 | $397K | Buy |
4,326
+319
| +8% | +$30.6K | 0.03% | 209 |
|
|
2020
Q1 | $361K | Sell |
4,007
-57
| -1% | -$6.06K | 0.04% | 193 |
|
|
2019
Q4 | $461K | Sell |
4,064
-147
| -3% | -$16.1K | 0.04% | 191 |
|
|
2019
Q3 | $457K | Sell |
4,211
-58
| -1% | -$6.05K | 0.05% | 181 |
|
|
2019
Q2 | $416K | Sell |
4,269
-937
| -18% | -$85.5K | 0.05% | 191 |
|
|
2019
Q1 | $474K | Buy |
5,206
+1,228
| +31% | +$110K | 0.06% | 174 |
|
|
2018
Q4 | $362K | Sell |
3,978
-845
| -18% | -$79K | 0.05% | 181 |
|
|
2018
Q3 | $474K | Buy |
4,823
+173
| +4% | +$16K | 0.06% | 161 |
|
|
2018
Q2 | $398K | Buy |
+4,650
| New | +$388K | 0.06% | 162 |
|
|
2018
Q1 | – | Sell |
-4,050
| Closed | -$327K | – | 251 |
|
|
2017
Q4 | $327K | Buy |
+4,050
| New | +$324K | 0.06% | 142 |
|
|
2017
Q3 | – | Sell |
-2,292
| Closed | -$203K | – | 211 |
|
|
2017
Q2 | $203K | Buy |
+2,292
| New | +$193K | 0.04% | 179 |
|
Other funds holding MDT
Mission Wealth Management's MDT Position: Q2 2026 in Review
Mission Wealth Management increased its Medtronic (MDT) stake by 167% in Q2 2026, buying an estimated $572K and bringing the position to 11,330 shares worth $886K. The position accounts for 0.01% of the portfolio, ranked #512.
Mission Wealth Management first reported a position in MDT in Q2 2017 and has held it in 35 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Mission Wealth Management held 11,330 shares of Medtronic worth $886K as of Q2 2026.
- Mission Wealth Management bought 7,087 Medtronic shares in Q2 2026, an estimated $572K.
- Medtronic made up 0.01% of Mission Wealth Management's portfolio in Q2 2026, its #512 holding.
- Mission Wealth Management first reported a position in Medtronic in Q2 2017 and has held it in 35 quarters since.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.